About Oaktree Acquisition Corp. III Life Sciences
https://www.oaktreeacquisitioncorp.com/o...Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
CEO
Zaid Pardesi
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
AQR ARBITRAGE LLC
Shares:1.41M
Value:$15.04M
TORONTO DOMINION BANK
Shares:934K
Value:$9.94M
D. E. SHAW & CO., INC.
Shares:861.63K
Value:$9.17M
Summary
Showing Top 3 of 49
About Oaktree Acquisition Corp. III Life Sciences
https://www.oaktreeacquisitioncorp.com/o...Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $225.58K ▼ | $1.97M ▲ | 0% | $0.08 ▲ | $0 ▲ |
| Q2-2025 | $0 | $269.81K ▼ | $1.87M ▲ | 0% | $0.08 ▲ | $-269.81K ▼ |
| Q1-2025 | $0 | $444.8K ▲ | $1.66M ▲ | 0% | $0.07 ▲ | $1.66M ▲ |
| Q4-2024 | $0 | $303.71K ▲ | $1.38M ▲ | 0% | $0.06 ▲ | $-303.71K ▼ |
| Q3-2024 | $0 | $48.09K | $-48.09K | 0% | $-0 | $-48.09K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.33M ▼ | $201.25M ▲ | $8.25M ▲ | $-6.76M ▼ |
| Q2-2025 | $1.39M ▲ | $199.18M ▲ | $8.14M ▲ | $191.04M ▲ |
| Q1-2025 | $1.28M ▼ | $197.24M ▲ | $8.08M ▲ | $189.16M ▲ |
| Q4-2024 | $1.36M ▲ | $195.25M ▲ | $7.75M ▲ | $187.5M ▲ |
| Q3-2024 | $0 | $638.99K | $662.09K | $-23.09K |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.97M ▼ | $-56.52K ▲ | $191.99M ▲ | $-193.44M ▼ | $-56.52K ▼ | $-56.52K ▲ |
| Q2-2025 | $2.15M ▲ | $-132K ▼ | $250K ▲ | $0 ▼ | $28.32K ▼ | $-132K ▼ |
| Q4-2024 | $1.38M ▲ | $-89.69K ▼ | $-191.99M ▼ | $193.44M ▲ | $1.36M ▲ | $-89.69K ▼ |
| Q3-2024 | $-48.09K | $0 | $0 | $0 | $0 | $0 |
CEO
Zaid Pardesi
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
AQR ARBITRAGE LLC
Shares:1.41M
Value:$15.04M
TORONTO DOMINION BANK
Shares:934K
Value:$9.94M
D. E. SHAW & CO., INC.
Shares:861.63K
Value:$9.17M
Summary
Showing Top 3 of 49